tiprankstipranks
Camp4 Therapeutics initiated with an Outperform at William Blair
PremiumThe FlyCamp4 Therapeutics initiated with an Outperform at William Blair
3M ago
Camp4 Therapeutics initiated with an Outperform at Leerink
Premium
The Fly
Camp4 Therapeutics initiated with an Outperform at Leerink
3M ago
Camp4 Therapeutics initiated with an Overweight at JPMorgan
Premium
The Fly
Camp4 Therapeutics initiated with an Overweight at JPMorgan
3M ago
CalAmp reports Chapter 11 bankruptcy filing, restructuring support agreement
PremiumThe FlyCalAmp reports Chapter 11 bankruptcy filing, restructuring support agreement
8M ago
CAMP Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CAMP Upcoming Earnings Report: What to Expect?
9M ago
CalAmp says FY24 to be ‘another successful year’
Premium
The Fly
CalAmp says FY24 to be ‘another successful year’
10M ago
New Share Price & Shareholder Rights Risk for CalAmp Corp. – What’s the Latest?
PremiumMarket NewsNew Share Price & Shareholder Rights Risk for CalAmp Corp. – What’s the Latest?
1y ago
CalAmp price target lowered to 30c from 50c at Craig-Hallum
Premium
The Fly
CalAmp price target lowered to 30c from 50c at Craig-Hallum
1y ago
CalAmp reports Q3 GAAP EPS ($2.27), consensus (3c)
Premium
The Fly
CalAmp reports Q3 GAAP EPS ($2.27), consensus (3c)
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100